Back to the Top
The following message was posted to: PharmPK
See the following at the new Office of Translational Sciences (OTS)
"We foster novel drug development strategies through research and
application of statistical and mathematical modeling and simulation
techniques in the review and analysis of data in the areas of
exposure-response, pharmacokinetics, pharmacodynamics, pharmacogenomics,
bioequivalence assessment, clinical trials, quantitative risk
assessment, toxicology, and product quality assessment."
Yaning Wang, Ph.D.
Team Leader, Pharmacometrics
Office of Clinical Pharmacology
Office of Translational Science
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "New site for Office of Translational Sciences, FDA" as the subject
Support PharmPK by using the
Copyright 1995-2011 David W. A. Bourne (email@example.com)